# K060437: Excia Total Hip System with U-Cap

- Pathway: 510(k) (Special)
- Applicant: Aesculap, Inc.
- Decided: Mar 22, 2006 after 29 days
- Product code: MEH (Prosthesis, Hip, Semi-Constrained, Uncemented, Metal / Polymer, Non-Porous, Calcium Phosphate)
- Device class: 2
- Regulation: 21 CFR 888.3353
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 6 generations back to K955033 (1996). 68 ancestors in all.
90 later devices descend from it; 5 cite it directly.
0 of 158 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K042344: Excia Total Hip System, Aesculap, Inc. (2005) Summary page 2.
- K043079: Bicontact Hip System with U-Cap, Aesculap (2004) Summary page 2.
- K001448: Trident Acetabular Shells: PS-HA, Howmedica Osteonics Corp. (2000) Summary page 2.

## Most influential descendants
- K080584: Metha Short Stem Hip System (2008), 83 descendants of its own
- K071916: Metha Hip System (2008), 68 descendants of its own
- K082991: Biolox Delta Ceramic Femoral Head (2008), 63 descendants of its own
- K083495: Modification to: Metha Hip System (2009), 59 descendants of its own
- K090845: Apex Arc Hip Stem (2010), 58 descendants of its own

## Indications for use
The Excia Hip System is intended to replace a hip joint. The device is intended for: Patients suffering from severe hip and disability due to rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis, collagen disorders, avascular necrosis of the femoral head and nonunion of previous fractures of the femur. Patients with congenital hip dysplasia, protrusion acetabuli, or slipped capital femoral epiphysis Patients suffering from disability due previous fusion Patients with acute femoral neck fractures The Excia Hip System is available with two femoral stems. One is manufactured from CoCrMo and is intended for cemented fixation. The other femoral stem is for uncemented fixation and manufactured from Ti with Plasmapore with or without p CaP®.

Source page: https://510kreport.com/device/K060437
Methodology: https://510kreport.com/methodology